v3.25.4
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Balance at beginning of period (in shares) at Jun. 01, 2024   70,377,692      
Balance at beginning of period at Jun. 01, 2024 $ 1,385.1 $ 14.1 $ 725.3 $ 738.4 $ (92.7)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net earnings (loss) (1.2)     (1.2)  
Other comprehensive income (loss), net of tax (5.8)       (5.8)
Stock-based compensation expense 9.1   9.1    
Exercise of stock options (in shares)   71,848      
Exercise of stock options 1.5   1.5    
Restricted and performance stock units released (in shares)   393,591      
Restricted and performance stock units released 0.2 $ 0.1 0.1    
Employee stock purchase plan issuances (in shares)   30,002      
Employee stock purchase plan issuances 0.8   0.8    
Repurchase and retirement of common stock and common stock withheld for tax withholdings (in shares)   (1,544,733)      
Repurchase and retirement of common stock and common stock withheld for tax withholdings (44.0) $ (0.3) (43.7)    
Dividends declared (13.2)     (13.2)  
Balance at end of period (in shares) at Aug. 31, 2024   69,328,400      
Balance at end of period at Aug. 31, 2024 1,332.5 $ 13.9 693.1 724.0 (98.5)
Balance at beginning of period (in shares) at Jun. 01, 2024   70,377,692      
Balance at beginning of period at Jun. 01, 2024 1,385.1 $ 14.1 725.3 738.4 (92.7)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net earnings (loss) 32.9        
Other comprehensive income (loss), net of tax (35.6)        
Balance at end of period (in shares) at Nov. 30, 2024   68,434,419      
Balance at end of period at Nov. 30, 2024 1,310.8 $ 13.7 680.3 745.1 (128.3)
Balance at beginning of period (in shares) at Aug. 31, 2024   69,328,400      
Balance at beginning of period at Aug. 31, 2024 1,332.5 $ 13.9 693.1 724.0 (98.5)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net earnings (loss) 34.1     34.1  
Other comprehensive income (loss), net of tax (29.8)       (29.8)
Stock-based compensation expense 8.8   8.8    
Exercise of stock options (in shares)   21,318      
Exercise of stock options 0.4   0.4    
Restricted and performance stock units released (in shares)   6,323      
Restricted and performance stock units released 0.4   0.4    
Employee stock purchase plan issuances (in shares)   32,251      
Employee stock purchase plan issuances 0.7   0.7    
Repurchase and retirement of common stock and common stock withheld for tax withholdings (in shares)   (955,646)      
Repurchase and retirement of common stock and common stock withheld for tax withholdings (23.4) $ (0.2) (23.2)    
Directors' fees (in shares)   1,773      
Directors' fees 0.1   0.1    
Dividends declared (13.0)     (13.0)  
Balance at end of period (in shares) at Nov. 30, 2024   68,434,419      
Balance at end of period at Nov. 30, 2024 $ 1,310.8 $ 13.7 680.3 745.1 (128.3)
Balance at beginning of period (in shares) at May. 31, 2025 67,804,913 67,804,913      
Balance at beginning of period at May. 31, 2025 $ 1,275.8 $ 13.6 679.1 665.1 (82.0)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net earnings (loss) 20.2     20.2  
Other comprehensive income (loss), net of tax 12.7       12.7
Stock-based compensation expense 9.3   9.3    
Exercise of stock options (in shares)   8,445      
Exercise of stock options 0.1   0.1    
Restricted and performance stock units released (in shares)   1,030,034      
Restricted and performance stock units released 0.3 $ 0.2 0.1    
Employee stock purchase plan issuances (in shares)   38,231      
Employee stock purchase plan issuances 0.7   0.7    
Repurchase and retirement of common stock and common stock withheld for tax withholdings (in shares)   (377,995)      
Repurchase and retirement of common stock and common stock withheld for tax withholdings (7.2) $ (0.1) (7.1)    
Dividends declared (13.1)     (13.1)  
Other 0.7     0.7  
Balance at end of period (in shares) at Aug. 30, 2025   68,503,628      
Balance at end of period at Aug. 30, 2025 $ 1,299.5 $ 13.7 682.2 672.9 (69.3)
Balance at beginning of period (in shares) at May. 31, 2025 67,804,913 67,804,913      
Balance at beginning of period at May. 31, 2025 $ 1,275.8 $ 13.6 679.1 665.1 (82.0)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net earnings (loss) 44.4        
Other comprehensive income (loss), net of tax $ (0.2)        
Balance at end of period (in shares) at Nov. 29, 2025 68,249,980 68,249,980      
Balance at end of period at Nov. 29, 2025 $ 1,299.7 $ 13.7 684.0 684.2 (82.2)
Balance at beginning of period (in shares) at Aug. 30, 2025   68,503,628      
Balance at beginning of period at Aug. 30, 2025 1,299.5 $ 13.7 682.2 672.9 (69.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net earnings (loss) 24.2     24.2  
Other comprehensive income (loss), net of tax (12.9)       (12.9)
Stock-based compensation expense 5.8   5.8    
Exercise of stock options (in shares)   6,500      
Exercise of stock options 0.1   0.1    
Restricted and performance stock units released (in shares)   14,070      
Restricted and performance stock units released 0.3   0.3    
Employee stock purchase plan issuances (in shares)   46,301      
Employee stock purchase plan issuances 0.6   0.6    
Repurchase and retirement of common stock and common stock withheld for tax withholdings (in shares)   (320,519)      
Repurchase and retirement of common stock and common stock withheld for tax withholdings (5.0)   (5.0)    
Dividends declared (13.1)     (13.1)  
Other $ 0.2     0.2  
Balance at end of period (in shares) at Nov. 29, 2025 68,249,980 68,249,980      
Balance at end of period at Nov. 29, 2025 $ 1,299.7 $ 13.7 $ 684.0 $ 684.2 $ (82.2)